68 related articles for article (PubMed ID: 28921208)
1. Electrophysiologic effects of volatile anesthetics, sevoflurane and halothane, in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
J Anesth; 1994 Mar; 8(1):93-100. PubMed ID: 28921208
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of halothane and propranolol on the effective refractory period and the ventricular activation in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
J Pharmacobiodyn; 1992 Nov; 15(11):623-30. PubMed ID: 1289497
[TBL] [Abstract][Full Text] [Related]
3. Effects of volatile anesthetics, enflurane, isoflurane, and halothane on ventricular delayed activation in a canine myocardial infarction model.
Imamura S; Hashimoto H; Ikeda K; Nakashima M
J Electrocardiol; 1994 Jan; 27(1):41-8. PubMed ID: 8120477
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic interaction between class I antiarrhythmic drugs and volatile anesthetics in depressant effects on ventricular activation in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
Jpn J Pharmacol; 1994 Apr; 64(4):235-41. PubMed ID: 8057524
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction between class I antiarrhythmic drugs and halothane in depressant effects on ventricular activation in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
Biol Pharm Bull; 1994 Mar; 17(3):449-53. PubMed ID: 8019516
[TBL] [Abstract][Full Text] [Related]
6. Effects of astemizole on ventricular activation, effective refractory periods, RT intervals, and programmed stimulation-induced ventricular arrhythmias in dog hearts with myocardial infarction.
Hashimoto H; Nishimoto M; Ohmura T; Watanabe S; Ikeda Y; Nakamura R; Umemura K; Nakashima M
J Cardiovasc Pharmacol; 1998 Feb; 31(2):286-91. PubMed ID: 9475271
[TBL] [Abstract][Full Text] [Related]
7. Effects of astemizole on ventricular activation delay and RT intervals in a canine myocardial infarction model.
Nishimoto M; Hashimoto H; Ohmura T; Ikeda Y; Watanabe S; Ohashi K; Umemura K; Nakashima M
Biol Pharm Bull; 1997 Sep; 20(9):1020-3. PubMed ID: 9331990
[TBL] [Abstract][Full Text] [Related]
8. Cardiac rhythm and left ventricular function of infants at 1 MAC sevoflurane and halothane.
Saudan S; Beghetti M; Spahr-Schopfer I; Mamie C; Habre W
Paediatr Anaesth; 2007 Jun; 17(6):540-6. PubMed ID: 17498015
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous anesthetics, thiopental, fentanyl, and morphine on ventricular delayed activation in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
Biol Pharm Bull; 1993 Dec; 16(12):1226-30. PubMed ID: 8130771
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic effects of nitrous oxide, a volatile anesthetic, in dogs following myocardial infarction in comparison with other anesthetics.
Hashimoto H; Imamura S; Watanabe S; Oomura T; Suzuki Y; Ikeda K; Nakashima M
Biol Pharm Bull; 1997 Jan; 20(1):82-5. PubMed ID: 9013813
[TBL] [Abstract][Full Text] [Related]
11. Anesthetic modulation of myocardial ischemia and reperfusion injury in pigs: comparison between halothane and sevoflurane.
Conradie S; Coetzee A; Coetzee J
Can J Anaesth; 1999 Jan; 46(1):71-81. PubMed ID: 10078408
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
Katoh H; Ogawa S; Furuno I; Sato Y; Yoh S; Saeki K; Nakamura Y
J Pharmacol Exp Ther; 1990 Jun; 253(3):1077-82. PubMed ID: 2359016
[TBL] [Abstract][Full Text] [Related]
13. Anesthetic potency and cardiopulmonary effects of sevoflurane in goats: comparison with isoflurane and halothane.
Hikasa Y; Okuyama K; Kakuta T; Takase K; Ogasawara S
Can J Vet Res; 1998 Oct; 62(4):299-306. PubMed ID: 9798097
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide in an Experimental Canine Model of Pacing-induced Atrial Fibrillation.
Feld GK; Cha Y
J Cardiovasc Pharmacol Ther; 1997 Jul; 2(3):195-203. PubMed ID: 10684458
[TBL] [Abstract][Full Text] [Related]
15. Differing electrophysiologic effects of slow response inhibiting agents manganese and verapamil on ischemic, infarcted and normal tissue in situ.
Kupersmith J; Cohen R
J Pharmacol Exp Ther; 1980 Nov; 215(2):394-400. PubMed ID: 7441504
[TBL] [Abstract][Full Text] [Related]
16. Effects of sevoflurane and halothane on reperfusion-induced arrhythmia in the isolated rat heart.
Tanaka K; Nakamura M; Umeda T; Izumi T; Takura M; Tsujimura K; Suekane K; Yamamoto F
Clin Ther; 1993; 15(6):1085-93. PubMed ID: 8111806
[TBL] [Abstract][Full Text] [Related]
17. The echocardiographic assessment of left ventricular performance during sevoflurane and halothane anesthesia.
Kasuda H; Akazawa S; Shimizu R
J Anesth; 1990 Oct; 4(4):295-302. PubMed ID: 15235959
[TBL] [Abstract][Full Text] [Related]
18. The comparative cardiovascular effects of sevoflurane with halothane and isoflurane.
Kazama T; Ikeda K
J Anesth; 1988 Mar; 2(1):63-8. PubMed ID: 15235835
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant effects of sevoflurane on amygdaloid kindling and bicuculline-induced seizures in cats: comparison with isoflurane and halothane.
Murao K; Shingu K; Miyamoto E; Ikeda S; Nakao S; Masuzawa M; Yamada M
J Anesth; 2002; 16(1):34-43. PubMed ID: 14566494
[TBL] [Abstract][Full Text] [Related]
20. Modelling changes in transmural propagation and susceptibility to arrhythmia induced by volatile anaesthetics in ventricular tissue.
Zhang H; Tao T; Kharche S; Harrison SM
J Theor Biol; 2009 Mar; 257(2):279-91. PubMed ID: 19135456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
